Eli Lilly, Ozempic competitor, launches "Big Night" ad campaign ahead of Oscars, urging against "vanity" use of weight-loss medicines.
Eli Lilly, maker of a competitor drug to Ozempic, launches a new ad campaign ahead of the Oscars, urging against the "vanity" use of medicines for weight loss. The ad, titled "Big Night," emphasizes that the medications are intended for people whose health is affected by obesity, not for cosmetic reasons. The campaign comes amid growing celebrity use of type 2 diabetes drugs for weight loss, sparking both backlash and fascination.
March 07, 2024
4 Articles